ASGE Annual GI Advanced Practice Provider Course (On-Demand) - Clinical Case-Based Learning (Day Two) | April 2023-Evaluation and Management of IBD

Pdf Summary

The document discusses the evaluation and management of inflammatory bowel disease (IBD). It highlights the differentiating features of Crohn's Disease (CD) and Ulcerative Colitis (UC) and provides information on the risk factors and diagnostic tests for IBD. The document also explores the guiding principles of IBD management, including the importance of early treatment and the concept of treating to target. It discusses the therapeutic agents used for the treatment of IBD, such as corticosteroids, aminosalicylates, immunomodulators, biologics, and small-molecule therapies. The document emphasizes the role of therapeutic drug monitoring (TDM) in optimizing treatment outcomes and provides proposed drug concentration targets for different medications. It also highlights the issue of health disparities in IBD and the need to address them. The document concludes with a case study and practice pearls for healthcare providers treating patients with IBD.

Asset Subtitle

Kimberly Kearns, MS, APN-BC

Keywords

inflammatory bowel disease

Crohn's Disease

Ulcerative Colitis

IBD management

therapeutic agents

early treatment

drug concentration targets

therapeutic drug monitoring

health disparities

healthcare providers